서브이미지
HOME > 자료실 > 문헌자료

문헌자료

ㆍ 제목 Gene patents, patenting life and the impact of court rulings on US stem cell patents and research
ㆍ 조회수 472 ㆍ 등록일시 2017-01-02 15:08:14
ㆍ 작성자 관리자
ㆍ 첨부파일

 

 발행년

 2014

 구분

 국외학술지

 학술지명

 Regenerative Medicine

 관련링크

 http://www.futuremedicine.com/doi/full/10.2217/rme.13.93

 

 

 

 

Gene patents, patenting life and the impact of court rulings on US stem cell patents and research

 

  • ​저자명

Kirstin RW Matthews, Maude L Cuchiara

  • 학술지명

Regenerative Medicine

  • 권호사항

Vol. 9, Nol 2

  • 발행처

Regenerative Medicine

  • 자료유형

국외학술지

  • 수록면

191-200

  • 언어

English

  • 발행년도

2014. 03

 

 

  • Abstract

In June 2013, the US Supreme Court ruled that naturally occurring genes were unpatentable in the case Association for Molecular Pathology v. Myriad Genetics . Up until this decision, Myriad Genetics was the only company in the USA that could legally conduct diagnostic testing for BRCA1 and 2 , genes that are linked to familial breast and ovarian cancer. The court case and rulings garnered discussion in public about patenting biological materials. This paper will describe the progression of the Myriad Genetics case, similar US rulings and biological intellectual property policies. In addition, it will discuss the impact of the case on biological patents - specifically those for human embryonic stem cells.

 

 

 

 

 

 

ㆍ 이전글 The fate and future of patents on human genes and genetic diagnostic methods
ㆍ 다음글 The scope of patent protection for gene technology in China